XML 100 R90.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segments - Adjusted EBITDA by Reportable Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021
Segment Reporting Information [Line Items] |  |  |  |
Segment Adjusted EBITDA for reportable segments | $ (12,071) | $ (11,044) | $ (30,587) | $ (28,743)
Biopharmaceuticals |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Segment Adjusted EBITDA for reportable segments | (12,417) | (12,661) | (35,286) | (34,055)
Exemplar |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Segment Adjusted EBITDA for reportable segments | $ 346 | $ 1,617 | $ 4,699 | $ 5,312

X
- Definition Segment Adjusted EBITDA defined as net income (loss) before (i) interest expense, (ii) income tax expense/benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid; (vi) adjustments for accrued bonuses paid in equity awards; (vii) gain or loss on disposal of assets; (viii) loss on impairment of goodwill and other noncurrent assets, (ix) write-off of reacquired in-process research and development, (x) equity in net income (loss) of affiliates, and (xi) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold. + References No definition available. + Details
Name: | pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
Namespace Prefix: | pgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pgen_BiopharmaceuticalsSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |